Chimerix logo
Chimerix CMRX

Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024

report update icon

Chimerix Langfristiger Schuldenstrom 2011-2025 | CMRX

Langfristiger Schuldenstrom Jährlich Chimerix

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
642 K 573 K - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
642 K 573 K 608 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
425 K $ 4.75 -0.94 % $ 788 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
481 K $ 3.05 0.16 % $ 236 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 1.17 - $ 6.38 M chinaChina
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 209.68 -1.47 % $ 5 B danmarkDanmark
Aptevo Therapeutics Aptevo Therapeutics
APVO
800 K $ 0.6 -35.15 % $ 166 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.16 2.1 % $ 7.6 B australiaAustralia
BioVie BioVie
BIVI
74.5 K $ 1.18 -7.09 % $ 1.74 M usaUSA
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
5.38 M - -15.15 % $ 60.3 M britainBritain
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
BioNTech SE BioNTech SE
BNTX
39.5 M $ 94.23 -0.84 % $ 27.2 B germanyGermany
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
6.8 M $ 26.87 0.22 % $ 1.3 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
17.6 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 0.22 25.66 % $ 479 M israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
1.6 M $ 9.49 0.13 % $ 139 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
11 M - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
3.29 M - -7.31 % $ 87 M usaUSA
bluebird bio bluebird bio
BLUE
21.2 M - - $ 546 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
1.37 M - -10.95 % $ 876 K usaUSA
Axon Enterprise Axon Enterprise
AXON
9.45 M $ 587.62 -0.6 % $ 44.5 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.48 -1.98 % $ 15.6 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
339 M $ 92.58 0.14 % $ 96.9 B britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
210 K $ 12.49 0.95 % $ 822 M usaUSA
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.45 M $ 26.14 -2.57 % $ 1.68 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
59 K $ 2.59 -6.34 % $ 31.7 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
675 K $ 10.86 0.51 % $ 702 M usaUSA
Biogen Biogen
BIIB
86.4 M $ 175.92 -0.23 % $ 25.6 B usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
3.4 M - - $ 7.29 B usaUSA